BlackRock Institutional Trust’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$69.1M	Buy	2,397,396 +86,715	+4%	+$2.29M	0.01%	1139
2016 Q3	$73.5M	Buy	2,310,681 +116,594	+5%	+$3.95M	0.01%	1053
2016 Q2	$71.2M	Buy	2,194,087 +101,128	+5%	+$3.38M	0.01%	1034
2016 Q1	$58.5M	Buy	2,092,959 +114,358	+6%	+$2.49M	0.01%	1123
2015 Q4	$70.5M	Buy	1,978,601 +86,501	+5%	+$3.05M	0.01%	1033
2015 Q3	$62.6M	Sell	1,892,100 -69,342	-4%	-$2.89M	0.01%	1110
2015 Q2	$82.1M	Sell	1,961,442 -462,936	-19%	-$17.9M	0.01%	1016
2015 Q1	$79M	Buy	2,424,378 +363,768	+18%	+$12.5M	0.01%	1060
2014 Q4	$65.4M	Sell	2,060,610 -57,578	-3%	-$1.63M	0.01%	1118
2014 Q3	$52.4M	Sell	2,118,188 -126,020	-6%	-$2.95M	0.01%	1222
2014 Q2	$50.7M	Buy	2,244,208 +19,033	+0.9%	+$397K	0.01%	1315
2014 Q1	$54.1M	Buy	2,225,175 +193,854	+10%	+$4.9M	0.01%	1226
2013 Q4	$50.8M	Buy	2,031,321 +33,997	+2%	+$802K	0.01%	1241
2013 Q3	$54.9M	Buy	1,997,324 +80,860	+4%	+$1.69M	0.01%	1141
2013 Q2	$34.8M	Buy	+1,916,464	New	+$26.4M	0.01%	1391